Warning letter
Health and Natural Beauty USA Corp.: warning letter of Jul 28, 2025
FDA warning letter 700187 · Center for Drug Evaluation and Research (CDER)
Key facts
| Reference number | 700187 |
|---|---|
| Company | Health and Natural Beauty USA Corp. |
| Subject | CGMP/Finished Pharmaceuticals/Adulterated |
| Issue date | Jul 28, 2025 |
| Posted date | Oct 14, 2025 |
| Issuing office | Center for Drug Evaluation and Research (CDER) |
| Product type | Drugs |
| CFR sections cited | 211.188(b), 201.66(b)(2), 201.128, 207.77(a), 211.22(a), 211.34, 211.84(d)(1), 211.100(a), 211.166(a), 211.194, 330 |
| Inspection city | Piscataway |
| Inspection ZIP | 08854 |
| Inspection start date | Oct 9, 2024 |
| Letter on fda.gov | fda.gov |
At a glance
- 10–99 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: